Validity of Prostate Health Index and Percentage of [-2] Pro-Prostate-Specific Antigen as Novel Biomarkers in the Diagnosis of Prostate Cancer: Omani Tertiary Hospitals Experience
Objectives: Prostate cancer is the leading cancer in older men. The Ministry of Health Oman Cancer Incidence Registry 2013 lists cancer of the prostate as the first most common cancer in males. Therefore, early detection is important and prostate-specific antigen (PSA) is widely used as an establish...
Main Authors: | Safana S. Al Saidi, Nafila B. Al Riyami, Mohammed S. Al Marhoon, Mohammed S. Al Saraf, Salim S. Al Busaidi, Riad Bayoumi, Waad-Allah S. Mula-Abed |
---|---|
Format: | Article |
Language: | English |
Published: |
Oman Medical Specialty Board
2017-07-01
|
Series: | Oman Medical Journal |
Subjects: | |
Online Access: | http://omjournal.org/articleDetails.aspx?coType=1&aId=2022 |
Similar Items
-
Clinicopathological Features, Treatment, and Outcome of Omani Patients with Metastatic Prostate Cancer
by: Shiyam Kumar, et al.
Published: (2022-01-01) -
Association of prostate volume with incidence and aggressiveness of prostate cancer
by: Al-Khalil S, et al.
Published: (2016-10-01) -
Extended use of Prostate Health Index and percentage of [-2]pro-prostate-specific antigen in Chinese men with prostate specific antigen 10–20 ng/mL and normal digital rectal examination
by: Peter Ka-Fung Chiu, et al.
Published: (2016-09-01) -
Determinants of behavioral intentions to screen for prostate cancer in Omani men
by: Joshua Kanaabi Muliira, et al.
Published: (2017-01-01) -
Nonspecific granulomatous prostatitis with prostatic adenocarcinoma
by: Murugan Paari, et al.
Published: (2010-01-01)